In recent trading, shares of Phillips 66 (Symbol: PSX) have crossed above the average analyst 12-month target price of $258.85, changing hands for $264.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati
In recent trading, shares of Delek Logistics Partners LP (Symbol: DKL) have crossed above the average analyst 12-month target price of $53.40, changing hands for $54.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr
The S&P 500 Index ($SPX ) (SPY ) closed up by +0.19% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.31%. December E-mini S&P futures (ESZ26 ) rose +0.20%, and December E-mini...
(RTTNews) - It has been a remarkable journey for Kodiak Sciences Inc. (KOD), whose share price has nearly tripled in just one month, climbing from around $37 on September 1, 2026, to $104 on October 1, 2026.
The average one-year price target for Hawaiian Electric Industries (NYSE:HE) (DB:HWI) has been revised to $8.24 / share on October 2, 2026. This is a decrease of 21.14% from the prior estimate of $10.46 dated September 11, 2026. These figures represent aggregate analyst targets a
The average one-year price target for Elmet Group (NASDAQCM:ELMT) has been revised to $23.46 / share. This is an increase of 10.84% from the prior estimate of $21.16 dated September 11, 2026. These figures represent aggregate analyst targets compiled as of September 29, 2026, and
(RTTNews) - Despite data showing a more than expected acceleration in Eurozone inflation in the month of September, German stocks climbed notably higher on Friday as bond yields dropped, and oil prices declined sharply.
The average one-year price target for Iovance Biotherapeutics (NASDAQGM:IOVA) (DB:2LB) has been revised to $13.06 / share. This is an increase of 34.74% from the prior estimate of $9.69 dated September 11, 2026. These figures represent aggregate analyst targets compiled from mult
The average one-year price target for BlossomHill Therapeutics (NASDAQGS:BLSM) has been revised to $37.48 / share. This is an increase of 10.53% from the prior estimate of $33.92 dated September 11, 2026. These figures represent an aggregate of analyst targets compiled by Fintel
The average one-year price target for Immutep Limited - Depositary Receipt (NASDAQGM:IMMP) has been revised to $69.75 / share. This is an increase of 917.93% from the prior estimate of $6.85 dated September 13, 2026. These figures represent aggregate analyst targ
The average one-year price target for Definium Therapeutics (NASDAQGS:DFTX) (DB:MMQ0) has been revised to $73.32 / share. This is an increase of 12.21% from the prior estimate of $65.34 dated September 11, 2026. These figures represent an aggregate of analyst targets and do not c
The average one-year price target for Okta (NASDAQGS:OKTA) (DB:0OK) has been revised to $216.95 / share. This is an increase of 16.50% from the prior estimate of $186.23 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not cons